SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization. Global Tuberculosis Control, Epidemiology, Strategy, Financing. Geneva: World Health Organization, 2009.
  • 2
    Grange J, Adhikari M, Ahmed Y, Mwaba P, Dheda K, Hoelscher M, et al. Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in sub-Saharan Africa. Int J Gynaecol Obstet 2010;108:1813.
  • 3
    Khan M, Pillay T, Moodley JM, Connolly CA. Maternal mortality associated with tuberculosis–HIV-1 co-infection in Durban, South Africa. AIDS 2001;15:185763.
  • 4
    Black V, Brooke S, Chersich MF. Effect of human immunodeficiency virus treatment on maternal mortality at a tertiary center in South Africa: a 5-year audit. Obstet Gynecol 2009;114:2929.
  • 5
    Kothari A, Mahadevan N, Girling J. Tuberculosis and pregnancy – results of a study in a high prevalence area in London. Eur J Obstet Gynecol Reprod Biol 2006;126:4855.
  • 6
    Knight M, Kurinczuk JJ, Nelson-Piercy C, Spark P, Brocklehurst P. Tuberculosis in pregnancy in the UK. BJOG 2009;116:5848.
  • 7
    Centers for Disease Control and Prevention. Decrease in reported tuberculosis cases – United States, 2009. MMWR Morb Mortal Wkly Rep 2010;59:28994.
  • 8
    Dye C. Global epidemiology of tuberculosis. Lancet 2006;367:93840.
  • 9
    World Health Organization. Global Tuberculosis Control: A Short Update to the 2009 Report. Geneva: World Health Organization, 2009.
  • 10
    Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners J Infect Dis 2005;191:1508.
  • 11
    Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009;23:171725.
  • 12
    Efferen LS. Tuberculosis and pregnancy. Curr Opin Pulm Med 2007;13:20511.
  • 13
    Maddineni M, Panda M. Pulmonary tuberculosis in a young pregnant female: challenges in diagnosis and management. Infect Dis Obstet Gynecol 2008;2008:628985.
  • 14
    Adhikari M. Tuberculosis and tuberculosis/HIV co-infection in pregnancy. Semin Fetal Neonatal Med 2009;14:23440.
  • 15
    Nachega J, Coetzee J, Adendorff T, Msandiwa R, Gray GE, McIntyre JA, et al. Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS 2003;17:1398400.
  • 16
    Kali PB, Gray GE, Violari A, Chaisson RE, McIntyre JA, Martinson NA. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr 2006;42:37981.
  • 17
    Deluca A, Chaisson RE, Martinson NA. Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health. J Acquir Immune Defic Syndr 2009;50:1969.
  • 18
    Schwartz N, Wagner SA, Keeler SM, Mierlak J, Seubert DE, Caughey AB. Universal tuberculosis screening in pregnancy. Am J Perinatol 2009;26:44751.
  • 19
    Nhan-Chang CL, Jones TB. Tuberculosis in pregnancy. Clin Obstet Gynecol 2010;53:31121.
  • 20
    Small PM, Pai M. Tuberculosis diagnosis – time for a game change. N Engl J Med 2010;363:10701.
  • 21
    Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:100515.
  • 22
    World Health Organization. Improving the Diagnosis and Treatment of Smear-Negative Pulmonary and Extrapulmonary Tuberculosis among Adults and Adolescents. Recommendations for HIV-Prevalent and Resource-Constrained Settings. Geneva: World Health Organization, 2007.
  • 23
    Getahun H, Harrington M, O’Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007;369:20429.
  • 24
    Francis J Curry National Tuberculosis Center. Tuberculosis Infection Control: A Practical Manual for Preventing TB. San Francisco, CA: Francis J Curry National Tuberculosis Center, 2007.
  • 25
    World Health Organization. Treatment of Tuberculosis Guidelines. Geneva: World Health Organization, 2010.
  • 26
    Tripathy SN. Tuberculosis and pregnancy. Int J Gynaecol Obstet 2003;80:24753.
  • 27
    Lessnau KD, Qarah S. Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature. Chest 2003;123:9536.
  • 28
    Shin S, Guerra D, Rich M, Seung KJ, Mukherjee J, Joseph K, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin Infect Dis 2003;36:9961003.
  • 29
    Drobac PC, del Castillo H, Sweetland A, Anca G, Joseph JK, Furin J, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis 2005;40:168992.
  • 30
    Palacios E, Dallman R, Munoz M, Hurtado R, Chalco K, Guerra D, et al. Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru. Clin Infect Dis 2009;48:14139.
  • 31
    Khan M, Pillay T, Moodley J, Ramjee A, Padayatchi N. Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa. Int J Tuberc Lung Dis 2007;11:7068.
  • 32
    Schiffer JT, Sterling TR. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defic Syndr 2007;44:22934.
  • 33
    McIlleron H, Meintjes G, Burman WJ, Maartens G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 2007;196(Suppl 1):S6375.
  • 34
    Cohen K, Meintjes G. Management of individuals requiring antiretroviral therapy and TB treatment. Curr Opin HIV AIDS 2010;5:619.
  • 35
    Maartens G, Decloedt E, Cohen K. Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries. Antivir Ther 2009;14:103943.
  • 36
    Inge LD, Wilson JW. Update on the treatment of tuberculosis. Am Fam Physician 2008;78:45765.
  • 37
    Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, et al. Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis 2010;50:128899.
  • 38
    Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006;367:92637.
  • 39
    Churchyard GJ, Scano F, Grant AD, Chaisson RE. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis 2007;196(Suppl 1):S5262.
  • 40
    Boggess KA, Myers ER, Hamilton CD. Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. Obstet Gynecol 2000;96:75762.
  • 41
    Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49:151.
  • 42
    Sackoff JE, Pfeiffer MR, Driver CR, Streett LS, Munsiff SS, DeHovitz JA. Tuberculosis prevention for non-US-born pregnant women. Am J Obstet Gynecol 2006;194:4516.
  • 43
    Lin HC, Chen SF. Increased risk of low birthweight and small for gestational age infants among women with tuberculosis. BJOG 2010;117:58590.
  • 44
    McIntyre J. Mothers infected with HIV. Br Med Bull 2003;67:12735.
  • 45
    Walson JL, Brown ER, Otieno PA, Mbori-Ngacha DA, Wariua G, Obimbo EM, et al. Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up. J Acquir Immune Defic Syndr 2007;46:20815.
  • 46
    Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008;12:2257.
  • 47
    Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009;48:10814.
  • 48
    Pillay T, Adhikari M, Mokili J, Moodley D, Connolly C, Doorasamy T, et al. Severe, rapidly progressive human immunodeficiency virus type 1 disease in newborns with coinfections. Pediatr Infect Dis J 2001;20:40410.
  • 49
    Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001;56:4949.
  • 50
    Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis 2004;4:15565.
  • 51
    Cohen JM, Whittaker E, Walters S, Lyall H, Tudor-Williams G, Kampmann B. Presentation, diagnosis and management of tuberculosis in HIV-infected children in the UK. HIV Med 2008;9:27784.
  • 52
    Marais BJ, Gupta A, Starke JR, El Sony A. Tuberculosis in women and children. Lancet 2010;375:20579.
  • 53
    Mofenson LM, Laughon BE. Human immunodeficiency virus, Mycobacterium tuberculosis, and pregnancy: a deadly combination. Clin Infect Dis 2007;45:2503.
  • 54
    Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, et al. The HIV-associated tuberculosis epidemic – when will we act? Lancet 2010;375:190619.